BIMI Holdings Company Description

BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People’s Republic of China and the United States.

The company operates through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail.

The Pharmacy Retail segment offers prescription and OTC medicines; TCM; healthcare supplies; traditional Chinese medicines; and sundry items.

The Wholesale Pharmaceuticals segment provides prescription; OTC medicines; TCM; healthcare supplies; and sundry items.

The Medical Device segment distributes medical devices, including medical consumables. The Healthcare products segment offers dietary supplements comprising cardiovascular products; anti-insomnia and depression products; male aphrodisiac products; menopausal syndrome products; gout products; and immunity products.

It sells its products through pharmacies; retail stores; private and government clinics; directly owned stores; third party pharmacies; hospitals; drug wholesalers; and medical device dealers.

The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024.

The company was incorporated in 2000 and is based in New York, New York.

BIMI Holdings Inc.

Country	United States
Founded	2000
Industry	Pharmaceutical Retailers
Sector	Healthcare
Employees	296
CEO	Tiewei Song

Contact Details

Address: 725 5th Avenue New York, New York 10022 United States
Phone	212 542 0028

Stock Details

Ticker Symbol	BIMI
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US05552Q2021
SIC Code	5122

Key Executives

Name	Position
Tiewei Song	Chief Executive Officer and Director
Baiqun Zhong	Interim Chief Financial Officer
Xiaoping Wang	Chief Operating Officer
Fnu Oudom	Chairman of Board and President